FDA Investigates Allergic Reactions To Pfizer Vaccine Reported In Multiple States


The Food and Drug Administration (FDA) is investigating allergic reactions to the Pfizer coronavirus vaccine that were reported in several states after it began to be administered this week.
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, told reporters on Friday evening that the reactions had been reported in more than one state besides Alaska and that the FDA was studying five reactions.

“We’re working hand in hand with the Centers for Disease Control and Prevention (CDC), and we’re actually working very closely with our colleagues in the UK, who of course have reported the allergic reaction. I think we’re going to look at all the data we can from each of these reactions to sort out exactly what happened, and we’ll also be looking to try to figure out which component of the vaccine might help produce them, ”Marks m ‘said.

“I think at this point we have the right… mitigation strategy with the availability of treatment for a severe allergic reaction ready, and we will continue to monitor it very closely,” he added.

Marks said the FDA was not certain of the cause of the reactions, but said a chemical called polyethylene glycol, found in vaccines produced by Pfizer and BioNTech as well as Moderna “could be the culprit.” He added that the reaction from some people may be more common than previously thought.

“We will obviously be watching very closely what is happening. We are working very closely with the CDC on these, and there have been meetings between the CDC and the FDA pretty much every day this week to make sure that we are monitoring what is happening very closely, ”a- he declared.

Reports of allergic reactions in Alaska follow two similar cases reported last week in Britain, the first nation to approve Pfizer’s vaccine.

Current FDA guidelines say most Americans with allergies should be allowed to take the vaccine, but people who have had severe reactions to other vaccines should not get the vaccine. He also said on Friday that people with a history of severe allergic reactions to any component of the Moderna vaccine should avoid getting the vaccine.

“The FDA takes the safety of the medical products that we authorize and approve very seriously, and certainly in the context of vaccination, which is one of the reasons why Dr. Marks and his team, in collaboration with the CDC, have set up a very robust monitoring system to assess safety. One of the things that the FDA does very well and in a unique way is really to get to the bottom of events such as allergic reactions so that we can fully understand the circumstances and better inform the public and our regulatory decisions, ”he said. said the commissioner of the FDA. Stephen HahnStephen Hahn The Hill’s Morning Report – Brought to you by Mastercard – COVID-19 Relief, Omnibus Talks Roll on The Hill’s Morning Report – Presented by Mastercard – Congress Strives to Relieve COVID-19, the omnibus agreement that the FDA first authorizes at home, on the test of the COVID-19 PLUS meter.


Please enter your comment!
Please enter your name here